Montealegre-Angarita M C, Llauradó-Paco S, Sabaté A, Ferreres E, Cabrera A, Camprubí I
Servicio de Anestesiologia, Reanimació i Unitat de Dolor, Hospital Universitari de Bellvitge, Universitat de Barcelona Health Campus, L'Hospitalet de Llobregat, Barcelona, España.
Rev Esp Anestesiol Reanim. 2013 Oct;60(8):434-9. doi: 10.1016/j.redar.2013.04.017. Epub 2013 Jun 27.
To determine the incidence of difficult tracheal intubation (DTI), as well as predictive factors for DTI and what influences the choice of the neuromuscular blocking agent (succinylcholine or rocuronium).
This is an observational, prospective study on consecutive bariatric surgery patients. Tracheal intubation was performed by direct laryngoscopy with a preformed tracheal tube. DTI was considered when there was a Cormack-Lehane classification of iii-iv or when it was necessary to apply the DTI algorithm, which consisted in the use of Frova guide, and Airtraq video-laryngoscope as second choice, and finally awaking the patient and sugammadex reversal if rocuronium was the selected neuromuscular blocking agent. Thereafter, tracheal intubation was performed using an awake fibroscopic technique
One hundred and sixty six patients were included. In one case, conscious fiberscope tracheal intubation was performed. Succinylcholine was selected for 14 patients, and rocuronium for 151 patients. Fifteen patients had a DTI (9%): in 4 Airtraq was deemed necessary. One patient received sugammadex to reverse neuromuscular blockade. Conscious tracheal intubation represented 1.2% (95% CI; 0.3-4%). DTI was associated with Mallampati score of 3-4 (odds ratio, 3 [95% CI; 1.37-6.8], sensitivity of 33%, specificity of 91%) and with thyromental distance<6cm (odds ratio, 4.8 [95% CI; 1.45-16]; sensitivity of 53%; specificity of 79%).
Rescue airway protocol with Frova and Airtraq avoided the use of sugammadex, except in one patient.
确定困难气管插管(DTI)的发生率、DTI的预测因素以及影响神经肌肉阻滞剂(琥珀胆碱或罗库溴铵)选择的因素。
这是一项针对连续肥胖手术患者的观察性前瞻性研究。采用预成型气管导管通过直接喉镜进行气管插管。当Cormack-Lehane分级为iii-iv级或需要应用DTI算法时,则判定为DTI,该算法包括首先使用弗罗瓦导丝,其次选择Airtraq视频喉镜,若选择罗库溴铵作为神经肌肉阻滞剂,则最后唤醒患者并使用舒更葡糖钠进行逆转。此后,采用清醒纤维支气管镜技术进行气管插管。
纳入166例患者。1例患者进行了清醒纤维支气管镜气管插管。14例患者选择了琥珀胆碱,151例患者选择了罗库溴铵。15例患者发生DTI(9%):其中4例认为需要使用Airtraq。1例患者接受舒更葡糖钠逆转神经肌肉阻滞。清醒气管插管占1.2%(95%CI;0.3-4%)。DTI与Mallampati评分3-4分相关(比值比,3[95%CI;1.37-6.8],敏感性33%,特异性91%),与甲颏距离<6cm相关(比值比,4.8[95%CI;1.45-16];敏感性53%;特异性79%)。
除1例患者外,采用弗罗瓦导丝和Airtraq的气道救援方案避免了舒更葡糖钠的使用。